Aldeyra’s sights set on November PDUFA; Synbio startup scores cash
Aldeyra Therapeutics has a date at the FDA, specifically Nov. 23 for its dry eye disease drug.
After boldly claiming …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
